Diuretic Efficiency of a Single Dose of Subcutaneous Versus Oral Furosemide After Heart Failure Hospitalization Across Diuretic Resistance Strata: A Pilot Randomized Controlled Trial
Open Access
- 2 December 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 27 (2) , 347-352
Abstract
Aims: Diuretic resistance (DR) in heart failure (HF) is associated with worse outcomes. Furoscix®, a self-administered subcutaneous (sc) furosemide injection administered via on-body infusor, is approved for HF congestion relief. However, its efficacy in patients with DR post-HF hospitalization remains unknown. Methods and results: In this open-label pilot randomized controlled trial, 70 participants were randomized within 14 days post-HF hospitalization to receive a single dose of 80 mg sc furosemide or home oral dose furosemide. Enrolment was stratified by presence of DR (admission BAN-ADHF score ≥12) with a 2:1 enrolment of those with versus without DR. Key outcomes included diuretic efficiency, the total urine output per mg of diuretic administered, and peak urine sodium within 8 h of dose administration. Treatment effects were calculated as the difference in estimated marginal means across study groups and DR strata using linear mixed-effect models. Overall, 70 participants were enrolled (57 years, 27% female, 70% Black, 79% with HF with reduced ejection fraction). Participants with DR (n = 46) had worse kidney function, higher N-terminal pro-B-type natriuretic peptide, and higher home diuretic dose. Among participants with DR, sc furosemide versus oral furosemide led to significantly greater diuretic efficiency (34.0 vs. 22.6 ml/mg, p = 0.002) and peak urine sodium (100 vs. 83 mmol/L, p = 0.029), while participants without DR had similar diuretic efficiency (29.8 vs. 30.1 ml/mg, p = 0.94) and peak urine sodium (96 vs. 95 mmol/L, p = 0.93) across both treatments. DR significantly modified the effect of sc versus oral furosemide on diuretic efficiency (pinteraction: treatment × diuretic resistance = 0.022). Conclusion: Single-dose sc furosemide was associated with greater diuretic efficiency and peak urine sodium than oral furosemide in participants with DR discharged following recent HF hospitalization.Keywords
This publication has 20 references indexed in Scilit:
- Avoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart FailureJACC: Heart Failure, 2024
- Diuresis Efficacy in Ambulatory Congested Heart Failure PatientsJACC: Heart Failure, 2024
- A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart FailureJACC: Heart Failure, 2023
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- Diuretic Strategies for Loop Diuretic Resistance in Acute Heart FailureJACC: Heart Failure, 2020
- Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot StudiesJournal of Cardiac Failure, 2019
- Subcutaneous Furosemide in Heart FailureJACC: Basic To Translational Science, 2018
- Diuretic response in acute heart failure—an analysis from ASCEND-HFAmerican Heart Journal, 2015
- Implications of intraindividual variability in bioavailability studies of furosemideEuropean Journal of Clinical Pharmacology, 1984
- Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysisEuropean Journal of Clinical Pharmacology, 1984